Peter Butterfield, Chief Executive Officer
Peter joined the board of Alliance in February 2010 following the acquisition of Cambridge Laboratories, where he spent five years, latterly as UK Commercial Director. With over 19 years industry experience, he has also served as a Board Member of the Association of the British Pharmaceutical Industry ("ABPI") and played a pivotal role in the 2014 PPRS negotiations with government.. Prior to joining Cambridge Laboratories, Peter spent six years at GlaxoSmithKline. He holds an honours degree in Pharmacology from the University of Edinburgh.